SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is experiencing increased attention, with community members pointing to its fully diluted status and potential for significant price movement. Conversations revolve around possible catalysts and the right timing for a breakout, with some drawing comparisons to other altcoins. Despite some skepticism, optimism persists, fueled by the belief that the project has underlying utility.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is trending amid community discussions around potential pumps and dumps, as well as speculation regarding future price movements and Binance futures. Some traders are debating whether to hold or take profits, while others are pointing to the upcoming Goliath mainnet launch as a potential catalyst. Overall, the community's sentiment appears mixed, with some expressing frustration over recent performance, and others still hopeful for long-term gains.

Intuition is the L2 for trusted data, and the world's first token-curated graph—allowing people and machines to get the information they need, when they need it, from the sources they trust. With Intuition, you can put your 'intuition' to work—transforming your thoughts, opinions, and experiences into fuel for personalized AI, recommendations, and ads that truly understand you. You fully control your digital identity and data—the most valuable resources of the digital age—enabling you to fully leverage their value while unlocking and democratizing trillions in economic potential. Bring your social graphs, preferences, and 'intuition' with you wherever you go. No more rebuilding your profile and connections from scratch on every new platform—create and curate a universal, portable identity and context that allows applications and AI across the web to understand you instantly. And as you contribute, you’re not just improving your own experience—you’re enhancing the web for everyone who follows and trusts your perspective.

Trust Community Token

Trust Community Token ($TRUST) is seeing active discussion around potential 'round 2' buying opportunities after an apparent sell-off, with some community members taking profits and moving to other tokens. Despite some negative sentiment and concerns about a potential rug pull, others remain optimistic, highlighting recent Coinbase listings and potential for significant gains during the altcoin season.

Banco de Chile SA engages in the provision of banking services. It operates through the following segments: Retail Banking, Wholesale Banking, Treasury, and Money Markets, and Subsidiaries. The Retail Banking segment consists of consumer loans, commercial loans, checking accounts, credit cards, credit lines, and mortgage loans. The Wholesale Banking segment includes corporate clients and large companies where the product offering focuses on commercial loans, checking accounts and liquidity management services, debt instruments, foreign trade, derivative contracts, and leases. The Treasury and Money Markets segment comprises securities portfolio, derivatives positions, and currency trading. The Subsidiaries segment corresponds to companies and corporations controlled by the bank. The company was founded on October 28, 1893 and is headquartered in Santiago, Chile.

Banco de Chile - ADR

Banco de Chile

Banco de Chile is trending due to a mix of options trading activity and analyst rating updates, including some upgrades. The community is discussing potential profit margins on call and put contracts, along with target entry and exit prices. Some analysts have updated their rating on Banco de Chile.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending amidst discussions around its recent integration with NatPay and speculation regarding future partnerships, including potential collaborations with Swift and J.P. Morgan. The community is weighing the significance of these developments, with some expressing excitement about Zebec's potential for real-world payment infrastructure and others remaining cautious. Participants are actively discussing staking opportunities and debating the impact of broader market trends, with some viewing the current price as a buying opportunity.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - 8% PRF PERPETUAL USD 100 - Ser A

Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock

STRK is trending as investors discuss its relationship to Strategy's Bitcoin holdings and dividend payouts. Community members are weighing the benefits and risks, particularly concerning potential dilution and the connection to $MSTR's performance. Bullish sentiment seems to be driven by confidence in Strategy's overall approach to BTC accumulation.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as traders discuss its potential to outperform Bitcoin, with some anticipating a significant breakout and drawing comparisons to Zcash's recent surge. Community members are closely watching technical indicators, with bullish sentiment fueled by the anticipation of an altcoin season and discussion of institutional adoption. Some users highlight Bitcoin Cash's utility for faster transactions compared to Bitcoin.

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita (DVA) is trending amid community discussion around potential catalysts, including TDAPA policy and adoption of DefenCath, with some suggesting Warren Buffett's Berkshire Hathaway may be trimming its stake. Technical analysis indicates potential bullish setups, although concerns persist around mortality rates and reimbursement pressures. Chatter also revolves around potential acquisitions and the impact of GLP-1 drugs on the dialysis sector.

Aventus Network

Aventus Network ($AVT) is trending amid community excitement surrounding its Polkadot integration and real-world enterprise partnerships with Vodafone and Heathrow. The recent addition of Dr. Marwan Al Zarouni as a strategic advisor to expand its reach in the UAE has sparked additional buzz. Traders are monitoring volume closely, anticipating potential catalysts like new exchange listings to drive price movement.

Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.

Evaxion A/S - ADR

Evaxion Biotech

EVAX is trending as investors discuss its AI-driven vaccine platform and potential partnerships, particularly with Merck, following positive data readouts and a recent business update. The community is focused on the upcoming ESMO presentation and anticipating further deals, fueling speculation about a buyout. Some are noting the company's cash runway into 2027 as a factor for long-term potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CytomX Therapeutics (NASDAQ:CTMX) Trading Down 7.1% - Here's Why

CytomX Therapeutics (NASDAQ:CTMX) Trading Down 7.1% - Here's Why...

CytomX Therapeutics (NASDAQ:CTMX) Shares Gap Down - Should You Sell?

CytomX Therapeutics (NASDAQ:CTMX) Shares Gap Down - What's Next...

What is HC Wainwright's Forecast for CTMX FY2025 Earnings?

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) - Investment analysts at HC Wainwright decreased their FY2025 earnings estimates for CytomX Therapeutics in a research note issued to investors...

CytomX Therapeutics (NASDAQ:CTMX) Price Target Raised to $10.00

HC Wainwright boosted their target price on shares of CytomX Therapeutics from $5.00 to $10.00 and gave the company a "buy" rating in a report on Tuesday...

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 12% - Time to Buy?

CytomX Therapeutics (NASDAQ:CTMX) Shares Up 12% - Here's Why...

CytomX Therapeutics (NASDAQ:CTMX) Earns Outperform Rating from Wedbush

Wedbush reissued an "outperform" rating and set a $6.00 price objective on shares of CytomX Therapeutics in a research report on Friday...

CytomX Therapeutics (NASDAQ:CTMX) Shares Gap Down After Earnings Miss

CytomX Therapeutics (NASDAQ:CTMX) Shares Gap Down on Disappointing Earnings...

CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -125.00% and -53.43%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

BioMarin Pharmaceutical (BMRN) Tops Q3 Earnings Estimates

BioMarin (BMRN) delivered earnings and revenue surprises of +180.00% and -1.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

CytomX Therapeutics (CTMX) Reports Break-Even Earnings for Q2

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of +100.00% and +2.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

CTMX
CytomX Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTMX News

CTMXCytomX Therapeutics Inc